Illumina IncNASDAQ:ILMN
- LAST PRICE140.5075
- TODAY'S CHANGE (%)-1.9925 (-1.3982%)
- Bid / Lots140.3900/ 1
- Ask / Lots140.6400/ 2
- Open / Previous Close142.2100 / 142.5000
- Day Range
- 52 Week Range
- Volume227,441
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ILMN |
|---|---|---|
| 09:32 ET | 21410 | 141.06 |
| 09:33 ET | 6780 | 142.155 |
| 09:35 ET | 2762 | 142.29 |
| 09:37 ET | 2139 | 142.29 |
| 09:39 ET | 4336 | 142.445 |
| 09:42 ET | 4049 | 143.22 |
| 09:44 ET | 3248 | 143.725 |
| 09:46 ET | 18644 | 143.53 |
| 09:48 ET | 1923 | 143.38 |
| 09:50 ET | 2270 | 143.355 |
| 09:51 ET | 1600 | 143.51 |
| 09:53 ET | 9280 | 142.4934 |
| 09:55 ET | 4185 | 142.195 |
| 09:57 ET | 2717 | 141.8331 |
| 10:00 ET | 1147 | 142.1114 |
| 10:02 ET | 3194 | 141.96 |
| 10:04 ET | 1505 | 141.885 |
| 10:06 ET | 1090 | 141.9 |
| 10:08 ET | 414 | 141.6118 |
| 10:09 ET | 1708 | 142.09 |
| 10:11 ET | 2209 | 141.75 |
| 10:13 ET | 542 | 141.29 |
| 10:15 ET | 720 | 141.1486 |
| 10:18 ET | 600 | 140.945 |
| 10:20 ET | 1500 | 140.79 |
| 10:22 ET | 2493 | 141.11 |
| 10:24 ET | 900 | 140.955 |
| 10:26 ET | 1400 | 140.76 |
| 10:27 ET | 1884 | 140.85 |
| 10:29 ET | 1773 | 140.595 |
| 10:31 ET | 6615 | 141.06 |
| 10:33 ET | 1500 | 141.4458 |
| 10:36 ET | 100 | 141.315 |
| 10:38 ET | 1075 | 141.2 |
| 10:40 ET | 3786 | 140.93 |
| 10:42 ET | 1622 | 140.73 |
| 10:44 ET | 3480 | 140.71 |
| 10:45 ET | 4763 | 140.645 |
| 10:47 ET | 1886 | 141.01 |
| 10:49 ET | 300 | 140.855 |
| 10:51 ET | 1483 | 140.795 |
| 10:54 ET | 925 | 140.94 |
| 10:56 ET | 1100 | 140.79 |
| 10:58 ET | 1320 | 140.51 |
| 11:00 ET | 3709 | 140.5075 |
Yesterday
Illumina To Webcast Upcoming Investor Conference, from 19 hours ago by Dow Jones
19 hours ago by Dow JonesSynaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications, from 3:30AM ET on Wednesday Dec 04, 2024 by Dow Jones
3:30AM ET on Wednesday Dec 04, 2024 by Dow Jones
Nov 27, 2024
DJ Trump's Unusual Pick for NIH Director May Be a Win for These Stocks -- Barrons.com, from 2:26PM ET on Wednesday Nov 27, 2024 by Dow Jones
2:26PM ET on Wednesday Nov 27, 2024 by Dow Jones
Nov 22, 2024
Trailblazing Study Shows Early CGP Leads to Better Precision Treatments, from 3:40PM ET on Friday Nov 22, 2024 by Dow Jones
3:40PM ET on Friday Nov 22, 2024 by Dow Jones
Nov 20, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Illumina Inc | 22.6B | -14.1x | --- |
Hologic Inc | 17.4B | 22.8x | --- |
Waters Corp | 23.2B | 36.5x | +7.16% |
Resmed Inc | 36.1B | 31.8x | +19.48% |
Revvity Inc | 14.1B | 54.8x | -7.39% |
Bruker Corp | 9.0B | 28.9x | +20.48% |
Company Information
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.
Contact Information
- Headquarters
- 5200 Illumina WaySAN DIEGO, CA, United States 92122-4616
- Phone
- 858-202-4500
- Fax
- 858-202-4766
Executives
- Independent Non-Executive Chairman of the Board
- Stephen Macmillan
- Chief Executive Officer, Director
- Jacob Thaysen
- Chief Financial Officer
- Ankur Dhingra
- Chief People Officer
- Patricia Leckman
- Chief Technology Officer
- Steve Barnard
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $22.6B |
|---|---|
Revenue (TTM) | $4.4B |
Shares Outstanding | 158.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.11 |
EPS | $-10.00 |
Book Value | $36.13 |
P/E Ratio | -14.1x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -26.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
